ArticlemedRxiv : the preprint server for health sciences2026
A custom phenotypic profile for Fanconi anemia: Addressing gaps in existing disease annotations.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Fanconi anemia (FA) is a rare genetic disorder of impaired DNA repair characterized by progressive bone marrow failure, congenital malformations, and cancer predisposition. Early identification of individuals with FA is critical for timely clinical management, yet phenotype-driven approaches to FA identification are hindered by inconsistencies in existing phenotypic profiles. We compared the Human Phenotype Ontology (HPO) annotations for FA in OMIM (215 terms across 22 complementation group entries) and Orphanet (106 terms in a single entry, ORPHA:84), quantifying overlap and anatomical system coverage. To address identified gaps, we developed a comprehensive custom HPO profile by extracting phenotypic terms from the entire Fanconi Cancer Foundation (FCF) Clinical Care Guidelines using OntoGPT, an LLM-based ontology extraction tool, followed by manual curation to ensure accuracy and clinical relevance. OMIM and Orphanet shared only 36 HPO terms (12.6% of their combined 285 unique terms), demonstrating substantial discordance. Our custom profile comprises 264 unique HPO terms, of which 161 (61.0%) are novel and not present in either existing source. The novel terms expand coverage particularly in musculoskeletal (39 terms, 23.8%), genitourinary (26 terms, 15.9%), limb (26 terms, 15.9%), head or neck (20 terms 12.2%), and digestive system (17 terms, 10.4%) phenotypes. Community-curated phenotypic profiles derived from clinical practice guidelines can substantially augment existing disease annotations. Our FA profile, the most comprehensive HPO-based phenotypic characterization of FA to date, is publicly available and provides a foundation for improved clinical decision support and EHR-based computable phenotyping that can accelerate diagnosis for individuals with FA. Furthermore, the LLM-assisted approach offers generalizable methods to improve the diagnostic odyssey for all rare diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.